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On 11 to 13 March 2013, BioMed Central will be hosting its inaugural conference, Epigenetics & Chromatin:
Interactions and Processes, at Harvard Medical School, Cambridge, MA, USA. Epigenetics & Chromatin has now
launched a special article series based on the general themes of the conference.Over the past two decades we have witnessed the mer-
ging of two very different fields of study, epigenetics and
chromatin biochemistry. Epigenetic phenomena were
first described in the 1920s with the discovery of gene-
tically stable mutant alleles in Drosophila and maize that
displayed variegated clonal expression patterns. The field
of chromatin biochemistry began in earnest decades
later, revolutionized in the early 1970s with the discovery
that chromosomes are organized into nucleosomes
followed by the realization that different parts of the
genome interact with each other. Both epigenetics and
chromatin biochemistry were successfully applied to the
study of mechanisms responsible for gene regulation
and developmental programming in several model
organisms and in humans. By the end of the 20th
century, it had become clear that the effects on gene ex-
pression observed in epigenetic phenomena and during
development could only be fully understood in light of
chromatin-based mechanisms. While traditional genetic
and biochemical approaches to studying genetic regula-
tory mechanisms continue, the trend has been to apply
epigenetic and chromatin methodologies in combination,
especially taking advantage of innovations in proteomics,
genomics, microscopy and other technologies, combined
with the impressive progress in informatics.
Mergers do not come easily, and experts in one or the
other discipline have much to learn from one another,
both in terms of subject matter and technology. Epige-
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distribution, and reproduction in any mediumfunction, has documented a plethora of nuclear pheno-
mena that need to be explained, including developmental
decision-making, heritable gene silencing, heterochroma-
tin formation, dosage compensation and the development
of diseases such as cancer. Chromatin biochemistry,
driven in part by genomic technologies, has identified
proteins and other molecules that self-organize within the
nucleus to form dynamic chromatin configurations that
ultimately are responsible for chromosomal processes,
such as replication, transcription, mitosis, repair and re-
combination. The daunting biological complexity of the
even simple model systems and the many different experi-
mental strategies that have been developed to deal with
this complexity motivate a broadly based meeting cen-
tered around basic processes at the intersection of epige-
netics and chromatin.
The conference [1] organizers have identified 10 broad
topics with a strong emphasis on processes and in-
teractions. This emphasis is justified by recent exciting
progress in this rapidly changing field. For example, after
years of describing static chromatin modifications, we
are beginning to gain a glimpse into the dynamics of nu-
cleosome assembly and modification, the importance of
chromatin remodelers, histone chaperones and tran-
scriptional elongation complexes, and clarification of
their roles in development and disease. Other topics are
intended to span the range of interests of practitioners
in the field. After decades of thinking that methylation is
the only covalent modification of DNA, we have been
surprised in just the past few years by the discovery of a
methylcytosine oxidation pathway with important
implications for the stability of this epigenetic mark.
Similarly, although much is now known about how small
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long non-coding RNAs act to mediate epigenetic pro-
cesses, and it remains to be seen how prevalent they are
in regulating gene expression. The molecular basis for
epigenetic memory during development remains as yet
an unsolved problem, but enough is now known about
the players involved that there is reason to expect
breakthroughs soon. Finally, the large-scale organization
of the nucleus has undergone a dramatic increase in
resolution thanks to technological progress in both ge-
nomics and microscopy.
Based on the epigenetic interactions and processes
highlighted in the sessions, we have decided to launch a
new thematic series as a permanent record of the inva-
luable research presented at the conference. The series
will feature short Reviews, Commentaries, Opinion
pieces and Research written by the speakers, and will be
open to Research submissions.
We expect that gaining a better understanding of fun-
damental epigenetic and chromatin processes will result
in practical applications in medicine, agriculture and
technology. The hope that stem cell research might lead
to tissue engineering must be tempered by the realization
that iPS cells are genetically identical to the cells that they
are derived from and to the subsequent progenitor and
differentiated cells that follow, while we know little about
the epigenetic processes involved in these transitions.
Likewise, the hope that cancer can be treated with epige-
netic drugs must be tempered by our very incomplete
knowledge of the action of the chromatin targets of these
drugs and our realization that they are likely to be only a
part of a combination of therapies. While there is great ex-
pectation and an understandable emphasis on transla-
tional research in many quarters, we believe that the
challenges in understanding fundamental epigenetics and
chromatin processes remain bottlenecks in achieving
these goals. We expect that the free exchange of new
results and ideas at this meeting will help us meet these
challenges.
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